Arbor Biotechnologies
Industry
- Digital Health
- Artificial Intelligence
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
Other Names/Subsidiaries
- Arbor
- Serendipity Biosciences
Latest on Arbor Biotechnologies
The number of venture capital mega-rounds of $100m or more plummeted from 11 in January to just three in February, but appear to be on the rise again with five as of mid-March. Flagship Pioneering’s l
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Gilgamesh To Investigate Potent
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Coherus Ends TIGIT Pact With Junshi Des